GABA-A receptor differences in schizophrenia: a positron emission tomography study using [¹¹C]Ro154513

Area of Science:

• Neuroscience
• Psychiatry
• Radiology

Background:

• GABA signaling loss is a key hypothesis in schizophrenia pathogenesis.
• Reduced hippocampal alpha5-GABA-A receptors (α5-GABA_ARs) are observed postmortem in schizophrenia patients.
• In vivo evidence and symptom correlation for α5-GABA_ARs in schizophrenia remain unclear.

Purpose of the Study:

• To investigate in vivo α5-GABA_ARs availability in antipsychotic-free and medicated schizophrenia patients.
• To examine the relationship between α5-GABA_ARs availability and symptom severity.
• To test the GABA hypofunction hypothesis in schizophrenia.

Main Methods:

• Cross-sectional, case-control study using [¹¹C]Ro15-4513 Positron Emission Tomography (PET) and MRI.
• Thirty-one schizophrenia patients (10 antipsychotic-free) and 29 healthy controls underwent PET scans.
• Quantification of α5-GABA_ARs availability using total volume of distribution (V_T) derived from a two-tissue compartment model.

Main Results:

• Significantly lower hippocampal [¹¹C]Ro15-4513 V_T (α5-GABA_ARs availability) in antipsychotic-free patients compared to healthy controls (p < 0.05, effect size = 1.4).
• No significant difference in V_T was observed between medicated patients and controls (p = 0.64).
• A positive correlation was found between hippocampal [¹¹C]Ro15-4513 V_T and total PANSS scores in antipsychotic-free patients (r = 0.72, p = 0.044).

Conclusions:

• Antipsychotic-free schizophrenia patients exhibit reduced hippocampal α5-GABA_ARs availability in vivo.
• These findings support the hypothesis that GABA hypofunction is implicated in schizophrenia pathophysiology.
• The results highlight the potential role of α5-GABA_ARs in schizophrenia symptoms and disease mechanisms.